Annual Cash & Cash Equivalents
$83.51 M
+$18.77 M+28.99%
December 31, 2023
Summary
- As of February 9, 2025, DCPH annual cash & cash equivalents is $83.51 million, with the most recent change of +$18.77 million (+28.99%) on December 31, 2023.
- During the last 3 years, DCPH annual cash & cash equivalents has fallen by -$52.39 million (-38.55%).
Performance
DCPH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$91.23 M
+$7.72 M+9.25%
March 1, 2024
Summary
- As of February 9, 2025, DCPH quarterly cash and cash equivalents is $91.23 million, with the most recent change of +$7.72 million (+9.25%) on March 1, 2024.
- Over the past year, DCPH quarterly cash and cash equivalents has dropped by -$16.86 million (-15.60%).
Performance
DCPH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DCPH Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.0% | -15.6% |
| 3 y3 years | -38.5% | -15.6% |
| 5 y5 years | -71.6% | -15.6% |
DCPH Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.1% | -22.5% | -20.4% | -29.0% |
| 5 y | 5-year | -38.6% | -22.5% | -60.3% | -41.7% |
| alltime | all time | -71.6% | -69.1% | -73.7% | -41.7% |
Deciphera Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $91.23 M(+9.2%) |
| Dec 2023 | $83.51 M(+29.0%) | $83.51 M(-22.7%) |
| Sep 2023 | - | $108.09 M(+32.8%) |
| Jun 2023 | - | $81.39 M(-29.0%) |
| Mar 2023 | - | $114.64 M(+77.1%) |
| Dec 2022 | $64.74 M(-25.6%) | $64.74 M(-21.6%) |
| Sep 2022 | - | $82.54 M(-24.8%) |
| Jun 2022 | - | $109.70 M(+15.1%) |
| Mar 2022 | - | $95.33 M(+9.5%) |
| Dec 2021 | $87.06 M(-35.9%) | $87.06 M(+63.7%) |
| Sep 2021 | - | $53.19 M(-41.5%) |
| Jun 2021 | - | $90.95 M(-54.9%) |
| Mar 2021 | - | $201.65 M(+48.4%) |
| Dec 2020 | $135.90 M | $135.90 M(+22.3%) |
| Sep 2020 | - | $111.15 M(-28.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $155.45 M(-32.3%) |
| Mar 2020 | - | $229.65 M(+90.9%) |
| Dec 2019 | $120.32 M(-59.0%) | $120.32 M(-30.7%) |
| Sep 2019 | - | $173.71 M(+203.5%) |
| Jun 2019 | - | $57.24 M(-30.4%) |
| Mar 2019 | - | $82.23 M(-72.0%) |
| Dec 2018 | $293.76 M(+49.3%) | $293.76 M(-8.4%) |
| Sep 2018 | - | $320.88 M(-7.4%) |
| Jun 2018 | - | $346.53 M(+92.7%) |
| Mar 2018 | - | $179.87 M(-8.6%) |
| Dec 2017 | $196.75 M(+242.4%) | $196.75 M(+139.5%) |
| Sep 2017 | - | $82.15 M(-12.6%) |
| Jun 2017 | - | $93.99 M(+63.6%) |
| Dec 2016 | $57.46 M(+122.9%) | $57.46 M |
| Dec 2015 | $25.78 M | - |
FAQ
- What is Deciphera Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Deciphera Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Deciphera Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of DCPH is $83.51 M
What is the all time high annual cash & cash equivalents for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high annual cash & cash equivalents is $293.76 M
What is Deciphera Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, DCPH annual cash & cash equivalents has changed by +$18.77 M (+28.99%)
What is Deciphera Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DCPH is $91.23 M
What is the all time high quarterly cash and cash equivalents for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high quarterly cash and cash equivalents is $346.53 M
What is Deciphera Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, DCPH quarterly cash and cash equivalents has changed by -$16.86 M (-15.60%)